✦ LIBER ✦

Integrating antiangiogenic therapy for advanced urothelial carcinoma: rationale for a phase II study of gemcitabine, cisplatin, and sunitinib

✍ Scribed by Matthew D. Galsky

Book ID: 118628320
Publisher: Frontline Medical Communications, Inc.
Year: 2010
Tongue: English
Weight: 75 KB
Volume: 7
Category: Article
ISSN: 1548-5315
DOI: 10.1016/s1548-5315(11)70600-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of gemcitabine and doce

A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma

✍ Barbara J. Gitlitz; Carole Baker; Yvonne Chapman; Heather J. Allen; Linda D. Bos 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

## Abstract ## BACKGROUND The objectives of the current study were to evaluate the safety and efficacy of gemcitabine plus docetaxel in patients with unresectable (Stage T4 or ≥ N1) metastatic or locally advanced transitional cell carcinoma (TCC) of the urothelial tract. ## METHODS A total of 27

Gemcitabine, Cisplatin, and Sunitinib fo

Gemcitabine, Cisplatin, and Sunitinib for Metastatic Urothelial Carcinoma and as Preoperative Therapy for Muscle-Invasive Bladder Cancer

✍ Galsky, Matthew D.; Hahn, Noah M.; Powles, Thomas; Hellerstedt, Beth A.; Lerner, 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 322 KB

Phase I/II study of a combined gemcitabi

Phase I/II study of a combined gemcitabine, etoposide, and cisplatin chemotherapy regimen for metastatic urothelial carcinoma

✍ Tetsuro Tsukamoto; Junji Yonese; Yuhei Ohkubo; Iwao Fukui 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

## Abstract ## BACKGROUND The authors attempted to determine the maximum tolerated dose (MTD) of gemcitabine in combination with etoposide and cisplatin as a chemotherapy regimen and investigated the safety and antitumor activity with the recommended doses of gemcitabine with etoposide and cisplat

Gemcitabine and docetaxel as first-line

Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: a phase II study

✍ Ardavanis, A; Tryfonopoulos, D; Alexopoulos, A; Kandylis, C; Lainakis, G; Rigato 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 97 KB

Phase II trial of first-line chemotherap

Phase II trial of first-line chemotherapy with gemcitabine, etoposide, and cisplatin for patients with advanced urothelial carcinoma

✍ Urakami, Shinji; Fujii, Yasuhisa; Yamamoto, Shinya; Yuasa, Takeshi; Kitsukawa, S 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 195 KB

PHASE II STUDY OF PACLITAXEL AND CISPLAT

PHASE II STUDY OF PACLITAXEL AND CISPLATIN FOR ADVANCED UROTHELIAL CANCER

✍ BURCH, PATRICK A.; RICHARDSON, RONALD L.; CHA, STEPHEN S.; SARGENT, DANIEL J.; P 📂 Article 📅 2000 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 391 KB